More than Money: Lidco
Like many British healthcare companies, Lidco (LON: LID) sees the US as the main geography for growth. But rather than gather up the dregs of the blood monitoring market, the company has hurled itself headlong into competition with its biggest competitor. Lidco's chief executive Matt Sassone thinks Lidco has the tools to emerge from the battle victorious, in our latest podcast, he explained to us why he's confident that the US can produce the growth that shareholders have long been waiting for.
Sign up for more great content
Register to continue reading this article.
Already a member? Login
Previous article Next article